fenofibrate has been researched along with Aortic Incompetence in 2 studies
Pharmavit: a polyvitamin product, comprising vitamins A, D2, B1, B2, B6, C, E, nicotinamide, & calcium pantothene; may be a promising agent for application to human populations exposed to carcinogenic and genetic hazards of ionizing radiation; RN from CHEMLINE
| Excerpt | Relevance | Reference |
|---|---|---|
| "Treatment with fenofibrate, a PPARα agonist, normalized both FA and glucose uptake while reducing LV dilation caused by AR." | 1.42 | Transcriptional Changes Associated with Long-Term Left Ventricle Volume Overload in Rats: Impact on Enzymes Related to Myocardial Energy Metabolism. ( Arsenault, M; Couet, J; Dhahri, W; Drolet, MC; Gascon, S; Lachance, D; Lecomte, R; Rousseau, JA; Roussel, E; Sarrhini, O; Walsh-Wilkinson, E, 2015) |
| "Fenofibrate is a peroxisome proliferator-associated receptor alpha agonist (PPARα) used clinically for the management of dyslipidemia and is a myocardial fatty acid oxidation stimulator." | 1.39 | Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload. ( Arsenault, M; Couet, J; Dhahri, W; Drolet, MC; Roussel, É, 2013) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Roussel, E | 2 |
| Drolet, MC | 2 |
| Walsh-Wilkinson, E | 1 |
| Dhahri, W | 2 |
| Lachance, D | 1 |
| Gascon, S | 1 |
| Sarrhini, O | 1 |
| Rousseau, JA | 1 |
| Lecomte, R | 1 |
| Couet, J | 2 |
| Arsenault, M | 2 |
2 other studies available for fenofibrate and Aortic Incompetence
| Article | Year |
|---|---|
Transcriptional Changes Associated with Long-Term Left Ventricle Volume Overload in Rats: Impact on Enzymes Related to Myocardial Energy Metabolism.
Topics: Animals; Aortic Valve Insufficiency; Cardiac Volume; Disease Models, Animal; Energy Metabolism; Feno | 2015 |
Fenofibrate reduces cardiac remodeling and improves cardiac function in a rat model of severe left ventricle volume overload.
Topics: Animals; Aortic Valve Insufficiency; Disease Models, Animal; Fatty Acids; Fenofibrate; Hypolipidemic | 2013 |